In recent years the incorporation of probiotic bacteria into foods has received increasing scientific interest for health promotion and disease prevention. The safety and probiotic properties of
Zymomonas mobilis
CP4 (UFPEDA-202) was studied in a Wistar rat model fed the 10
9 colony forming units (cfu)/mL
-1 of the assayed strain for 30 days. No abnormal clinical signs were noted in the group receiving viable cells of
Z. mobilis and water (control) during the period of the experiment. There were no significant difference (p > 0.05) in feed intake and weight gain among mice fed the
Z. mobilis in comparison to the control group. No bacteria were found in blood, liver and spleen of any animals. Mice receiving
Z. mobilis showed significantly differences (p < 0.05) in total and differential leucocytes count, excepting for neutrophils, after the experimental period. Otherwise, it was not found in control group. Histological examination showed that feeding mice with
Z. mobilis caused no signs of adverse effects on gut, liver and spleen. From these results,
Z. mobilis CP4 (UFEPEDA-202) is likely to be nonpathogenic and safe for consumption, and could have a slight modulating effect on immunological performance in mice.
